Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$88,076
+$88,076 QoQ
Shares Held
562
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,386
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in NVS
reported options exposure · as of Jun 30, 2026CallValue
$141,048
CallShares
900
PutValue
$423,144
PutShares
2,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Limestone Investment Advisors LP holds $1,815,578 across 3 Drug Manufacturers - General names. NVS ranks #3 (4.9% of the industry book) .
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,076 | 562 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $141,048 | 900 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $423,144 | 2,700 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $213,850 | 1,400 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $30,550 | 200 | Call | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||